IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: marvin friedman who wrote (1260)	9/13/1997 11:52:00 PM
From: Webhead	of 1762

Sure, IDEC would be breaking new ground but the size of the market will matter a lot more that the novelty of the treatment. My understanding is that the relapsed, Non-Hodgekins market is of modest size and sufficient to bring the company into the black, expecially with the indium coupled Indium agent and the second generation treatment with yttrium. Off the top of my head I don't recall what some analyst prediced about revenue but somehow 30M next year and 70M for 1999 stick in my mind. So I'ld be cautious about throwing out a >$60 figure without more things dribbling out the end of the pipeline. Just MHO, Ed

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next